The Use and Misuse of Oxygen During the Neonatal Period

Clinics in Perinatology

Volumn 39, Issue 1, 2012, Pages 165-176

  Vento, Máximo ^a,b   Escobar, Javier ^b   Cernada, María ^b   Escrig, Raquel ^a   Aguar, Marta ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

Newborn; Oxidative stress; Oxygen; Oxygen saturation; Oxygen toxicity; Pulse oximetry

Indexed keywords

ADENOSINE TRIPHOSPHATE; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AEROBIC METABOLISM; ARTERIAL OXYGEN SATURATION; DRUG MISUSE; DRUG USE; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HOME OXYGEN THERAPY; HUMAN; HYPEROXIA; INFLAMMATION; LIPID PEROXIDATION; LUNG DYSPLASIA; NEWBORN INTENSIVE CARE; NEWBORN PERIOD; OXIDATIVE STRESS; OXYGEN THERAPY; PERINATAL ASPHYXIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY CHAIN; RESUSCITATION; RETROLENTAL FIBROPLASIA; REVIEW;

ANTIOXIDANTS; FREE RADICALS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE UNITS, NEONATAL; OXIDATIVE STRESS; OXYGEN; OXYGEN INHALATION THERAPY;

EID: 84857088282     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2011.12.014     Document Type: Review

References (41)

1. Maltepe E., Saugstad O.D. Oxygen in health and disease. Pediatr Res 2009, 65:261-268.
2. Buonocore G., Perrone S., Tataranno M.L. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010, 15:186-190.
3. Brunelle J.K., Chandel N.S. Oxygen deprivation induced cell death: an update. Apoptosis 2002, 7:475-482.
4. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 2007, 35:1147-1150.
5. Davis J.M., Auten R.L. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010, 15:191-195.
6. Lu S.C. Regulation of glutathione synthesis. Mol Aspects Med 2009, 30:42-59.
7. Jones D.P., Go Y.M., Anderson C.L., et al. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 2004, 18:1246-1248.
8. Gao Y., Raj J.U. Regulation of pulmonary circulation in the fetus and newborn. Physiol Rev 2010, 90:1291-1335.
9. Khaw K.S., Ngan Kee W.D., Chu C.Y., et al. Effect of different inspired oxygen fractions on lipid peroxidation during general anaesthesia for elective Caesarean section. Br J Anaesth 2010, 105:355-360.
10. Vento M., Aguar M., Escobar J., et al. Antenatal steroids and antioxidant enzyme activity in preterm infants: influence of gender and timing. Antioxid Redox Signal 2009, 11:2945-2955.
11. Vento M., Saugstad O.D. Role of management in the delivery room and beyond in the evolution of bronchopulmonary dysplasia. Bronchopulmonary Dysplasia 2010, 292-313. Informa Healthcare USA Inc, New York. 1st edition. S.H. Abman (Ed.).
12. Dawson J.A., Kamlin C.O., Vento M., et al. Defining the reference range for oxygen saturation for infants after birth. Pediatrics 2010, 125:e1340-e1347.
13. Dawson J.A., Vento M., Finer N.N., et al. Managing oxygen therapy during delivery room stabilization of preterm infants. J Pediatr 2012, 160:158-161.
14. Saugstad O.D., Ramji S., Soll R.F., et al. Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic meta-analysis. Neonatology 2008, 94:176-182.
15. Saugstad O.D. Resuscitation of newborn infants: from oxygen to air. Lancet 2010, 376:1970-1971.
16. Vento M., Saugstad O.D. Oxygen supplementation in the delivery room: updated information. J Pediatr 2011, 158:e5-e7.
17. Perlman J.M., Wyllie J., Kattwinkel J., et al. Part 11: Neonatal Resuscitation: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010, 122:S516-S538.
18. Vento M., Cheung P.Y., Aguar M. The first golden minutes of the extremely low gestational age neonate: a gentle approach. Neonatology 2009, 95:286-298.
19. Rabi Y. Oxygen in the delivery room. Neoreviews 2010, 11:e130-e138.
20. Escrig R., Arruza L., Izquierdo I., et al. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentrations: a prospective, randomized trial. Pediatrics 2008, 121:875-881.
21. Wang C.L., Anderson C., Leone T.A., et al. Resuscitation of preterm neonates by using room air or 100% oxygen. Pediatrics 2008, 121:1083-1089.
22. Vento M., Moro M., Escrig R., et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation and chronic lung disease. Pediatrics 2009, 124:439-449.
23. Saugstad O.D. Optimal oxygenation at birth and in the neonatal period. Neonatology 2007, 91:319-322.
24. Tin W., Milligan D.W., Pennefather P., et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001, 84:F106-F110.
25. Askie L.M., Henderson-Smart D.J., Irwig L., et al. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003, 349:959-967.
26. Sola A. Avoiding hyperoxia in infants < or = 1,250 g is associated with improved short- and long-term outcomes. J Perinatol 2006, 26:700-705.
27. Saugstad O.D. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 2010, 28:1-7.
28. Ellis R.M. Reactive carbonyls and oxidative stress: potential for therapeutic interventions. Pharmacol Ther 2007, 115:13-24.
29. Winterbourn C.C., Chan T., Buss I.H., et al. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res 2000, 48:84-90.
30. Ballard P.L., Truog W.E., Merrill J.D., et al. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics 2008, 121:555-561.
31. Ahola T., Fellman V., Kjellmer I., et al. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004, 56:88-93.
32. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 2010, 15:223-229.
33. The STOP-ROP Multicenter Study Group Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial: I primary outcomes. Pediatrics 2000, 105:295-310.
34. Carlo W.A., Finer N.N., Walsh M.C., et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010, 362:1959-1969.
35. Stenson B., Brocklehurst P., Tarnow-Mordi W. Increased 36-week survival with high oxygen saturation target in extremely preterm. N Engl J Med 2011, 364:1680-1682.
36. Saugstad O.D., Aune D. In search of the optimal saturation for extremely low birth weight infants: a systematic review and meta-analysis. Neonatology 2011, 100:1-8.
37. Solberg R., Enot D., Deigner H.P., et al. Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010, 5:e9606.
38. Saletti A., Stick S., Doherty D., et al. Home oxygen therapy after preterm birth in Western Australia. J Paediatr Child Health 2004, 40:519-523.
39. Fitzgerald D.A., Massie R.J.H., Nixon G.M., et al. Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy. Med J Aust 2008, 189:578-582.
40. Lagatta J., Clark R., Spitzer A. Clinical predictors and institutional variation in home oxygen use in preterm. J Pediatr 2011, [Epub ahead of print].
41. Harrison G., Beresford M., Shaw N. Acute life threatening events among infants on home oxygen. Paediatr Nurs 2006, 18:27-29.